Clinical Trial Update: Determination of Remifentanil's ED50 for Rapid Sequence Intubation Avoiding Bradycardia and Hypotension in Adults [Phase 3]

View source ↗

Summary

Phase 3 trial updating the ED50 of remifentanil for rapid sequence intubation to avoid bradycardia and hypotension in adults. Study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bradycardia
• Hypotension

Drugs mentioned

• Remifentanil (remifentanil)

Snippet

Sponsor: Brasilia University Hospital | Conditions: Bradycardia, Hypotension | Phase 3 | Status: COMPLETED